Table 2.
Incidence of other cancers in NTHL1 families compared to non-NTHL1 families in BEACCON study.
Family historya | NTHL1 familiesb n = 22 | Non-NTHL1 familiesc n = 3239 | OR | 95% CI | p Value | ||
---|---|---|---|---|---|---|---|
Cancer (%) | Non-cancer | Cancer (%) | Non-cancer | ||||
Breast cancer | 28 (6.93) | 376 | 3929 (6.46) | 56,872 | 1.08 | 0.71–1.59 | 0.68 |
Male breast cancer | 1 (0.25) | 403 | 77 (0.13) | 60,724 | 1.96 | 0.05–11.29 | 0.40 |
Colorectal cancer | 9 (2.23) | 395 | 1559 (2.56) | 59,242 | 0.87 | 0.39–1.66 | 0.87 |
Ovarian cancer | 6 (1.49) | 398 | 541 (0.89) | 60,260 | 1.68 | 0.61–3.71 | 0.18 |
aCancer affected family members in the first and second degree of relatives of index cases.
bNTHL1 families, families in which the index cases carry a germline monoallelic LoF variant in NTHL1.
cNon-NTHL1 families, families in which the index cases do not carry any LoF variants in NTHL1.